15317 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 307 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x
HSPBP1HSPA (Hsp70) binding protein 1Predicted intracellular proteins
Vesicles
Cytosol
Expressed in all
HSPD1Heat shock protein family D (Hsp60) member 1Cancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
MitochondriaEndometrial cancer: 1.61e-4
Liver cancer: 2.25e-4
Expressed in all
HSPE1Heat shock protein family E (Hsp10) member 1Cancer-related genes
Plasma proteins
Predicted intracellular proteins
Expressed in all
HSPE1-MOB4HSPE1-MOB4 readthroughPredicted intracellular proteins
Mixed
HSPG2Heparan sulfate proteoglycan 2Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Nucleoplasm
Plasma membrane
Cytosol
Urothelial cancer: 2.82e-4
Expressed in all
HSPH1Heat shock protein family H (Hsp110) member 1Cancer-related genes
Predicted intracellular proteins
Nucleoplasm
Cytosol
Liver cancer: 1.41e-5
Head and neck cancer: 4.90e-4
Expressed in all
HTATIP2HIV-1 Tat interactive protein 2Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
CytosolLiver cancer: 2.86e-4
Pancreatic cancer: 6.18e-4
Renal cancer: 8.01e-4
Expressed in all
HTATSF1HIV-1 Tat specific factor 1Predicted intracellular proteins
NucleoplasmRenal cancer: 8.13e-8
Cervical cancer: 3.78e-4
Expressed in all
HTN3Histatin 3Predicted secreted proteins
Transporters
VesiclesTissue enriched
HTR1A5-hydroxytryptamine receptor 1ADisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Group enriched
HTR1B5-hydroxytryptamine receptor 1BFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Plasma membraneTissue enhanced
HTR1E5-hydroxytryptamine receptor 1EFDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Tissue enhanced
HTR1F5-hydroxytryptamine receptor 1FFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
HTR2A5-hydroxytryptamine receptor 2AFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enriched
HTR2B5-hydroxytryptamine receptor 2BFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
NucleoplasmTissue enhanced
HTR3A5-hydroxytryptamine receptor 3AFDA approved drug targets
Predicted membrane proteins
Transporters
Endometrial cancer: 1.26e-4
Cervical cancer: 6.26e-4
Group enriched
HTR3B5-hydroxytryptamine receptor 3BFDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
HTR3E5-hydroxytryptamine receptor 3EFDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
HTR45-hydroxytryptamine receptor 4FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
HTR5A5-hydroxytryptamine receptor 5AG-protein coupled receptors
Predicted membrane proteins
Tissue enriched
HTR75-hydroxytryptamine receptor 7FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
RAS pathway related proteins
Nuclear speckles
Plasma membrane
Cytosol
Group enriched
HTRA1HtrA serine peptidase 1Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
Plasma membraneRenal cancer: 7.90e-7
Urothelial cancer: 5.62e-6
Glioma: 8.66e-4
Mixed
HTRA2HtrA serine peptidase 2Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted membrane proteins
MitochondriaLiver cancer: 7.77e-8
Mixed
HTRA3HtrA serine peptidase 3Enzymes
Predicted secreted proteins
VesiclesRenal cancer: 1.61e-9
Thyroid cancer: 1.29e-4
Mixed
HTRA4HtrA serine peptidase 4Enzymes
Predicted secreted proteins
Tissue enriched
HTTHuntingtinDisease related genes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Cytosol
Renal cancer: 2.41e-12
Head and neck cancer: 3.26e-4
Expressed in all
HUNKHormonally up-regulated Neu-associated kinaseEnzymes
Predicted intracellular proteins
Nucleoplasm
Plasma membrane
Renal cancer: 7.48e-5
Mixed
HUS1HUS1 checkpoint clamp componentPredicted intracellular proteins
Cervical cancer: 4.25e-5
Liver cancer: 9.54e-5
Mixed
HUWE1HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligaseCancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Cytosol
Expressed in all
HVCN1Hydrogen voltage gated channel 1Predicted intracellular proteins
Predicted membrane proteins
Transporters
Mixed
HYAL1Hyaluronoglucosaminidase 1Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
Renal cancer: 1.56e-11
Colorectal cancer: 2.07e-4
Tissue enhanced
HYAL2Hyaluronoglucosaminidase 2Enzymes
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
HYAL3Hyaluronoglucosaminidase 3Enzymes
Predicted intracellular proteins
Predicted secreted proteins
Urothelial cancer: 2.12e-5
Tissue enhanced
HYAL4Hyaluronoglucosaminidase 4Enzymes
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
HYDINHYDIN, axonemal central pair apparatus proteinDisease related genes
Predicted intracellular proteins
Plasma membrane
Cytosol
Tissue enhanced
HYIHydroxypyruvate isomerase (putative)Enzymes
Predicted intracellular proteins
Golgi apparatus
Plasma membrane
Cytosol
Urothelial cancer: 2.72e-5
Renal cancer: 2.75e-5
Colorectal cancer: 4.96e-4
Liver cancer: 5.55e-4
Breast cancer: 9.18e-4
Expressed in all
HYKKHydroxylysine kinaseEnzymes
Predicted intracellular proteins
Vesicles
Aggresome
Mixed
HYLS1HYLS1, centriolar and ciliogenesis associatedDisease related genes
Predicted intracellular proteins
Plasma membrane
Cytosol
Liver cancer: 1.92e-4
Tissue enriched
HYOU1Hypoxia up-regulated 1Plasma proteins
Predicted secreted proteins
Renal cancer: 5.10e-5
Endometrial cancer: 2.58e-4
Thyroid cancer: 5.00e-4
Expressed in all
HYPKHuntingtin interacting protein KPredicted intracellular proteins
Nucleoplasm
Microtubules
Mixed
HYPMHuntingtin interacting protein MPredicted intracellular proteins
Tissue enriched
IAPPIslet amyloid polypeptidePredicted intracellular proteins
Predicted secreted proteins
Tissue enriched
IARSIsoleucyl-tRNA synthetaseDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
CytosolLiver cancer: 4.98e-7
Expressed in all
IARS2Isoleucyl-tRNA synthetase 2, mitochondrialDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
MitochondriaPancreatic cancer: 9.24e-5
Cervical cancer: 1.04e-4
Expressed in all
IBA57IBA57 homolog, iron-sulfur cluster assemblyDisease related genes
Predicted intracellular proteins
MitochondriaRenal cancer: 1.71e-9
Mixed
IBTKInhibitor of Bruton tyrosine kinasePredicted intracellular proteins
NucleoplasmCervical cancer: 3.86e-4
Expressed in all
ICA1Islet cell autoantigen 1Predicted intracellular proteins
Predicted membrane proteins
Vesicles
Cytosol
Renal cancer: 4.23e-8
Mixed
ICA1LIslet cell autoantigen 1 likePredicted intracellular proteins
MitochondriaMixed
ICAM1Intercellular adhesion molecule 1Cancer-related genes
Candidate cardiovascular disease genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membrane
Cytosol
Renal cancer: 1.32e-6
Breast cancer: 7.09e-4
Expressed in all
ICAM3Intercellular adhesion molecule 3CD markers
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Nucleus
Nuclear membrane
Mitochondria
Expressed in all
« prev | Page of 307 | next »